Trial Profile
Prospective, Randomized, Single-Center Evaluation of the Cypher (TM) Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2019
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms BBK
- 01 Dec 2008 Results have been reported in the European Heart Journal 29: 2859-2867, No. 23, Dec 2008.